Stockreport

Corvus' (CRVS) Lymphoma Drug Gets Orphan Status, Stock Up [Yahoo! Finance]

Corvus Pharmaceuticals, Inc.  (CRVS) 
Last corvus pharmaceuticals, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corvuspharma.com
PDF The FDA generally grants this designation to investigational therapies that address rare medical diseases or conditions affecting fewer than 200,000 people in the Unite [Read more]